Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inflammation and Blood Brain Barrier Integrity as Biomarkers of Suicidal Behavior

NCT06047613 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT06047613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06047613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inflammation and Blood Brain Barrier Integrity as Biomarkers of Suicidal Behavior
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Unknown status
Start date
October 5, 2023
Completion date
October 31, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, suicide